1. Introduction
Monkeypox (Mpox) is a rare viral disease and an agent of the genus Orthopoxvirus. The illness, which is primarily seen in Central and West Africa, is comparable to smallpox, which was declared extinct in 1980. As a zoonotic virus, the Mpox virus most frequently infects humans through contact with rodents and primates that have the disease. Fever, chilliness, enlarged lymph nodes, headache, back pain, muscle aches, and fatigue are some of the symptoms of Mpox. A rash typically starts on the face before spreading to other body parts. Mpox can occasionally result in serious disease and even death, especially in people with weakened immune systems. The World Health Organization has recommended adding Mpox to its list of conditions that could cause a public health emergency of global concern (WHO). The disease was identified in humans for the first time in 1970, and periodic outbreaks have been noted. It is common in certain parts of Central and West Africa. Uncertainty still exists over the extent of Mpox transmission in Africa, which may be underreported1. In recent years few cases of Mpox have been documented in the United States and the United Kingdom, most usually among travelers from the affected African nations. Given that the Mpox virus is a zoonotic disease, it is crucial to understand the role that wildlife plays in its maintenance and dissemination. Hence, to control and halt the spread of the illness, a study on the epidemiology, ecology, and monitoring of Mpox is essential2-4.